Unfortunately, there were no statistically significant effects of AZD0530 treatment on the cerebral metabolic rate for glucose, cognitive functions and total brain or ventricular volume, and patients exhibited several adverse events; however, it showed a trend for slowing down the reduction in hippocampal volume and entorhinal thickness [ 52 ].
← all excerpts
Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation.
1
—
—